No title
Before a ligand is ready for commercial use as a drug, a long process of ligand optimization and understanding of the binding dynamics between the ligand and the drug target is required. One approach to tackling this is X-ray crystallography, which involves solving the structure of protein-ligand complexes. The information from the solved structures can be used to further optimize ligands until th
